GlassScriptPhysician profile
Andrew C Wilkins
NPI 1275760423
$4,559.83
in general payments reported to CMS, 2019-2025
20 companies · $892 in 2025
The $892 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $301 · 2021: $211 · 2022: $389 · 2023: $1,724 · 2024: $899 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,883 · Travel and Lodging: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,883.27 |
| Travel and Lodging | $632.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,115.79 | 2022-2023 | Intracept |
| Abbott Laboratories | $897.72 | 2023-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $650.39 | 2019-2025 | General - Pain Management, Intracept |
| Medtronic, INC. | $493.76 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $331.10 | 2019-2020 | |
| Mml US, INC. | $304.70 | 2024-2025 | Reactiv8 |
| Foundation Fusion Solutions, LLC | $184.12 | 2023 | |
| Horizon Therapeutics Plc | $150.89 | 2019-2022 | |
| Pylant Medical | $86.13 | 2023 | |
| Stratus Medical, LLC | $58.98 | 2023 | Nimbus |
| Nevro Corp. | $53.04 | 2023-2024 | Senza |
| Hydrocision, INC. | $51.89 | 2024-2025 | Tenjet |
| Averitas Pharma INC. | $32.15 | 2024 | Qutenza |
| Bioventus LLC | $24.98 | 2023 | Durolane |
| Stimwave Technologies Incorporated | $24.28 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $22.50 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.89 | 2025 | |
| Assertio Therapeutics, INC. | $21.40 | 2020 | |
| Amgen INC. | $19.12 | 2025 | Evenity |
| Spr Therapeutics, INC | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wilkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.